# Safety and efficacy of the BCL2 inhibitor venetoclax in estrogen receptor (ER) and BCL2-positive metastatic breast cancer: The mBEP study.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-and-efficacy-of-the-bcl2-inhibitor-venetoclax-in-estrogen-receptor-er-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Geoffrey John Lindeman,Sheau Wen Lok,Alice R.T. Bergin,James R. Whittle,Kylie Shackleton,Peter Sherman,Sarah‐Jane Dawson,Jayesh Desai,Danny Liew,G. Bruce Mann,Anand Murugasu,Andrew W. Roberts,Mark Rosenthal,Jane E. Visvader |
| Citations | 10 |
| DOI | 10.1200/jco.2017.35.15_suppl.1044 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2621547786 |
| Type | conference-abstract |
| Year | 2017 |

## Paper authors

- [Kylie Shackleton](https://scholariq.org/researchers/kylie-shackleton/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Paper topics

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.